ISIS Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx

[at noodls] – CARLSBAD, Calif., March 3, 2014/PRNewswire/ — Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the initiation … more

View todays social media effects on ISIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Isis is hiring next, click here to view